Remaining veterans left with hearing loss or tinnitus have until late next week to decide whether to opt in or out of the 3M Combat Arms earplugs settlement agreement.
A status report on Tepezza lawsuits is due on January 5, and will update the judge on the continuing preparations for early hearing loss litigation test trials.
Those wishing to opt-out of the 3M earplug settlement must take action by January 15 to inform the court.
This is the first of a series of 3M earplug settlement payments expected to take place between now and 2029, which will resolve more than 200,000 hearing loss and tinnitus claims brought by former military servicemembers.
Texas woman left with permanent hearing loss from Tepezza indicates in a recently filed lawsuit that the maker of the thyroid eye disease drug should have recommended audiological exams and monitoring during treatments.
Following case-specific discovery in an initial pool of 12 claims involving hearing problems from Tepezza, parties will select four lawsuits that will be eligible for the first bellwether trials in the federal multidistrict litigation (MDL).
3M has proposed using common stock to pay for $1 billion of its $6 billion earplug settlement agreement.
Report decribes a patient who suffered diabetic ketoacidosis that was likely caused by side effects of Tepezza, leading researchers to warn that the thyroid eye disease drug could pose serious risks for diabetes patients
As the latest 3M earplug settlement update is issued by the Court, there remain questions over whether enough veterans will sign onto the deal to finalize the pact, which would average about $24,000 per claim.
Former users allege that Horizon Therapeutics was aware of long-term Tepezza hearing complaints years before a warning label update in July 2023
